A Study of PLX51107 in Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
- Status
- COMPLETED
- Phase
- PHASE1
Caris Molecular Intelligence Registry
- Status
- TERMINATED
- Phase
- N/A
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
URMC Related Haplo-identical Donor BMT
- Status
- COMPLETED
- Phase
- PHASE1
The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment
- Status
- COMPLETED
- Phase
- NA